Authors: Beyer, BM Zhang, RM Hong, Z Madison, V Malcolm, BA

Citation: Bm. Beyer et al., Effect of naturally occurring active site mutations on hepatitis C virus NS3 protease specificity, PROTEINS, 43(2), 2001, pp. 82-88

Authors: Pan, SH Malcolm, BA

Citation: Sh. Pan et Ba. Malcolm, Reduced background expression and improved plasmid stability with pET vectors in BL21 (DE3), BIOTECHNIQU, 29(6), 2000, pp. 1234

Authors: Huang, YT Malcolm, BA Vederas, JC

Citation: Yt. Huang et al., Synthesis and testing of azaglutamine derivatives as inhibitors of hepatitis A virus (HAV) 3C proteinase, BIO MED CH, 7(4), 1999, pp. 607-619

Authors: Wang, WY Malcolm, BA

Citation: Wy. Wang et Ba. Malcolm, Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange (TM) site-directed mutagenesis, BIOTECHNIQU, 26(4), 1999, pp. 680-682

Authors: Bergmann, EM Cherney, MM Mckendrick, J Frormann, S Luo, C Malcolm, BA Vederas, JC James, MNG

Citation: Em. Bergmann et al., Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis a virus (HAV) and implications for the polyprotein processing in HAV, VIROLOGY, 265(1), 1999, pp. 153-163

Authors: Zhang, RM Beyer, BM Durkin, J Ingram, R Njoroge, FG Windsor, WT Malcolm, BA

Citation: Rm. Zhang et al., A continuous spectrophotometric assay for the hepatitis C virus serine protease, ANALYT BIOC, 270(2), 1999, pp. 268-275